Clinical Trial Update: Study of TV-1106 in Growth Hormone-Deficient Adults [Phase 3]

View source ↗

Summary

Phase 3 trial of TV-1106 in adults with growth hormone deficiency was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• TV-1106 (TV-1106)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Growth Hormone Deficiency | Phase 3 | Status: TERMINATED | Results posted: 2018-06-11